Aggeliki Lyberopoulou

Prompt initiation of high‐dose i.v. corticosteroids seems to prevent progression to liver failure in patients with original acute severe autoimmune hepatitis

Kalliopi Zachou, Pinelopi Arvaniti, Vasiliki Lygoura et al. · Hepatology Research · 2018 · 54 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +16

Predictors of hepatitis B surface antigen loss, relapse and retreatment after discontinuation of effective oral antiviral therapy in noncirrhotic HBeAg‐negative chronic hepatitis B

Μargarita Papatheodoridi, Emilia Hadziyannis, Françoise Berby et al. · Journal of Viral Hepatitis · 2019 · 52 citations

Medicine, Infectious Diseases, Pharmacology +17

TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting

George Fountzilas, Eleni Giannoulatou, Zoi Alexopoulou et al. · Oncotarget · 2016 · 37 citations · Full text

Medicine, Molecular Medicine, Oncology +16

MgcRacGAP Interacts with HIF-1α and Regulates its Transcriptional Activity

Aggeliki Lyberopoulou, Emmanouil Venieris, Ilias Mylonis et al. · Cellular Physiology and Biochemistry · 2007 · 36 citations

Life Sciences, Cell Biology, Molecular Biology +14

Low Serum Hepcidin in Patients with Autoimmune Liver Diseases

Aggeliki Lyberopoulou, Georgia Chachami, Nikolaos Gatselis et al. · PLoS ONE · 2015 · 29 citations · Full text

Medicine, Immunology, Pathology +15